Abstract:
This invention provides caspase inhibitors of formula I: wherein Z is oxygen or sulfur; R1 is hydrogen, —CHN2, R, CH2OR, CH2SR, or —CH2Y; Y is an electronegative leaving group; R2 is CO2H, CH2CO2H, or esters, amides or isosteres thereof; R3 is a group capable of fitting into the S2 subsite of a caspase enzyme; R4 and R5 are taken together with the intervening nitrogen to form heterocyclic ring and R is as described in the specification. The compounds are effective inhibitors of apoptosis and IL-1&bgr; secretion.
Abstract translation:本发明提供了式I的半胱天冬酶抑制剂:其中Z是氧或硫; R 1是氢,-CHN 2,R 1,CH 2 OR,CH 2 SR或-CH 2 Y; Y是电负离子团; R 2是CO 2 H,CH 2 CO 2 H或其酯,酰胺或等体积体; R 3是能够适应半胱天冬酶的S2亚位点的基团; R 4和R 5与中间的氮一起形成杂环,R如说明书中所述。 这些化合物是凋亡和IL-1β分泌的有效抑制剂。
Abstract:
This invention describes novel pyrazole compounds of formula I′: wherein Q′ is —O—, —C(R6′)2—, 1,2-cyclopropanediyl, 1,2-cyclobutanediyl, or 1,3-cyclopropanediyl, and R1 is T-Ring D, wherein Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rx and Ry are independently selected from T—R3 or L—Z—R3, or Rx and Ry are taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-7 membered ring having 0-3 heteroatoms; and R2 and R2′ are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
Abstract:
A process and apparatus are disclosed for estimating evaporative fuel emission losses from a vehicle having a hydrocarbon-fueled engine operating under control of a microprocessor-based powertrain controller, a fuel tank with an evaporated fuel emission control system comprising a fuel vapor adsorbtion means connected to the tank and engine, and a diagnostic system that detects malfunctions in the vapor adsorbtion means. The process and apparatus measures temperature inside the vehicle passenger compartment at successive times when the engine is not running and determines the lowest temperature during partial diurnal and diurnal cooling cycles and uses such temperature along with any malfunction data to estimate evaporated fuel loss during a test period.
Abstract:
A method for analyzing automotive vehicle emissions detects and logs significant engine events over a test period, and applies the logged events to a model defining the emissions impact of such events to yield a vehicle emissions estimate for the test period. The method includes a diagnostic for diagnosing a deviation in performance of emissions control systems away from an expected performance and for correcting the vehicle emissions estimated to reflect the operating condition of the emissions control systems.
Abstract:
A diffractive/refractive hybrid lens for use in an optical data storage system as an objective is provided by a convex-plano singlet having a refractive element defined by plano-convex surfaces and a diffractive element defined by a Fresnel zone-like pattern on the plano surface which together provide the total power of the lens. The refractive lens is made of a high index, high dispersion glass so that the curvature and thickness of the refractive lens is minimized while providing a large numerical aperture (at least 0.45) at the expense of increased longitudinal chromatic aberration, which are compensated by the diffractive element and without the need for one or more additional curved surfaces as in low index biaspheric glass objective lenses for chromatic and mono-chromatic aberration reduction, which increases the thickness and curvatures of the lens. The invention enables longitudinal chromatic aberration to be corrected for at least a 10 nm band width around a center wavelength over a 20 nm range, as results when different lasers are used and as laser power varies during optical data storage on an optical data storage device (an optical disk). The thin, light weight low curvature achromat has maximum tolerance for various possible manufacturing errors such as decentering, variations in thickness of the lens, tilt and focal length especially for on-axis field of view less than 2.degree. while providing a very high quality spot (Strehl ratio of at least 0.9.).
Abstract:
A system and method for entering text from a user includes a programmed processor that receives inputs from the user and disambiguates the inputs to present word choices corresponding to the text. In one embodiment, inputs are received in two or more modalities and are analyzed to present the word choices. In another embodiment, a keyboard is divided into zones each of which represents two more input characters. A sequence of zones selected by the user is analyzed to present word choices corresponding to the zone selected.
Abstract:
The present invention provides a facile process for the preparation of tri- and tetra—substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora—mediated diseases or conditions.
Abstract:
A gate valve comprises a valve body having an internal working fluid passage and an internal gate chamber extending transverse to the working fluid passage. In addition, the gate valve comprises a gate disposed in the internal gate chamber and movable within the gate chamber between a closed position obstructing fluid flow through the working fluid passage and an open position allowing fluid flow through the working fluid passage. Further, the gate valve comprises an internal sealing arrangement coaxially disposed in the working fluid passage and extending between the valve body and the gate to form a barrier between the internal working fluid passage and the gate chamber. The internal sealing arrangement includes a frustoconical metal sealing surface adapted to sealingly engage an opposed mating frustoconical metal sealing surface on the valve body to form a first tapered metal-to-metal seal between the sealing arrangement and the valve body.
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Abstract:
The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.